MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...
MSD has said it will cut $3 billion off its annual costs by the end of 2027 as it prepares for the end of patent protection for blockbuster cancer drug Keytruda the following year. The plan was ...
A returning feature in Metroid Prime 4: Beyond is the ability to scan important items, enemies, and allies into a comprehensive Scan Logbook to reveal essential information about the world, and to ...
Italy closes probe into DeepSeek after commitments to warn of AI 'hallucination' risks Italy’s antitrust authority has ended an investigation into the Chinese AI system DeepSeek for allegedly failing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback